CIK: 0001615982 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value ($000): $949,945 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 8,493,321 | $180,908 | 19.0% | $22.03 | 0.0% | COM | 03770N101 |
| — | RAYZEBIO INC | 4,016,847 | $89,174 | 9.4% | $22.20 | — | COM | 75525N107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,082,622 | $47,287 | 5.0% | $20.23 | -5.7% | COM | 92790C104 |
| COGT | COGENT BIOSCIENCES INC | 4,684,167 | $45,671 | 4.8% | $8.79 | +35.0% | COM | 19240Q201 |
| TSHA | TAYSHA GENE THERAPIES INC | 14,444,444 | $45,644 | 4.8% | $1.87 | 0.0% | COM SHS | 877619106 |
| — | MERUS N V | 1,726,214 | $40,704 | 4.3% | $18.62 | — | COM | N5749R100 |
| ELVN | ENLIVEN THERAPEUTICS INC | 2,954,902 | $40,364 | 4.2% | $19.48 | -13.6% | COM | 29337E102 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 3,000,000 | $38,190 | 4.0% | $18.41 | -9.2% | COM | 35104E100 |
| PHVS | PHARVARIS N V | 1,563,513 | $32,631 | 3.4% | $10.96 | +68.2% | COM | N69605108 |
| CABA | CABALETTA BIO INC | 1,973,253 | $30,033 | 3.2% | $3.87 | +253.4% | COM | 12674W109 |
| KALV | KALVISTA PHARMACEUTICALS INC | 2,916,667 | $28,088 | 3.0% | $5.36 | +90.7% | COM | 483497103 |
| GHRS | GH RESEARCH PLC | 2,744,125 | $27,578 | 2.9% | $17.34 | -33.3% | ORDINARY SHARES | G3855L106 |
| — | HILLEVAX INC | 2,037,313 | $27,402 | 2.9% | $13.45 | — | COM | 43157M102 |
| SVRA | SAVARA INC | 7,184,865 | $27,159 | 2.9% | $1.58 | +125.8% | COM | 805111101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 1,090,000 | $24,988 | 2.6% | $18.05 | +24.1% | COM | 76243J105 |
| — | AMBRX BIOPHARMA INC | 2,070,000 | $23,805 | 2.5% | $8.92 | — | SPONSORED ADS | 02290A102 |
| TVTX | TRAVERE THERAPEUTICS INC | 2,623,677 | $23,456 | 2.5% | $14.11 | 0.0% | COM | 89422G107 |
| DYN | DYNE THERAPEUTICS INC | 2,173,913 | $19,478 | 2.1% | $11.80 | -8.7% | COM | 26818M108 |
| CELC | CELCUITY INC | 2,105,386 | $19,243 | 2.0% | $10.24 | -3.9% | COM | 15102K100 |
| TERN | TERNS PHARMACEUTICALS INC | 3,092,273 | $15,554 | 1.6% | $3.82 | +66.2% | COM | 880881107 |
| — | MERSANA THERAPEUTICS INC | 11,328,000 | $14,387 | 1.5% | $1.27 | — | COM | 59045L106 |
| — | APPLIED THERAPEUTICS INC | 5,658,034 | $14,089 | 1.5% | $1.28 | — | COM | 03828A101 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,142,856 | $12,964 | 1.4% | $5.68 | +44.3% | COM | 68622P109 |
| DNTH | DIANTHUS THERAPEUTICS INC | 927,706 | $12,682 | 1.3% | $12.62 | 0.0% | COM | 252828108 |
| — | ADVERUM BIOTECHNOLOGIES INC | 6,573,300 | $9,860 | 1.0% | $1.55 | — | COM | 00773U108 |
| — | PRAXIS PRECISION MEDICINES I | 5,304,410 | $9,071 | 1.0% | $1.15 | — | COM | 74006W108 |
| — | ACELYRIN INC | 864,332 | $8,790 | 0.9% | $10.17 | — | COM | 00445A100 |
| TRVI | TREVI THERAPEUTICS INC | 3,422,397 | $7,461 | 0.8% | $2.46 | -8.3% | COM | 89532M101 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,040,754 | $7,129 | 0.8% | $13.57 | -37.0% | COM | 00461U105 |
| MIST | MILESTONE PHARMACEUTICALS IN | 2,208,812 | $6,847 | 0.7% | $7.58 | -59.0% | COM | 59935V107 |
| PLRX | PLIANT THERAPEUTICS INC | 288,949 | $5,010 | 0.5% | $21.42 | -19.1% | COM | 729139105 |
| SGMT | SAGIMET BIOSCIENCES INC | 515,000 | $4,532 | 0.5% | $13.31 | 0.0% | COM SER A | 786700104 |
| — | AEGLEA BIOTHERAPEUTICS INC | 295,034 | $3,614 | 0.4% | $0.45 | — | COM | 00773J103 |
| — | LYRA THERAPEUTICS INC | 924,170 | $3,614 | 0.4% | $5.65 | — | COM | 55234L105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 77,042 | $951 | 0.1% | $10.19 | 0.0% | COM | 68062P106 |
| — | RALLYBIO CORP | 268,532 | $905 | 0.1% | $7.55 | — | COM | 75120L100 |
| — | AFFIMED N V | 1,428,571 | $683 | 0.1% | $5.52 | — | COM | N01045108 |